cell carcinoma, Ringertz carcinoma, and respiratory epithelial carcinoma, Plich BZ, et al. [3] as the tumor is composed of malignant proliferating cells derived from the sinonasal respiratory (Schneiderian) epithelium [4] . The name cylindrical cell carcinoma was first coined by Ringertz [5] and was recommended as the preferred term by Shanmugaratnam in the WHO classification of 1991. [6] Sinonasal carcinoma (Squamous cell carcinoma and adenocarcinoma) are strongly associated with environmental factors, including tobacco, alcohol, and occupational exposure (e.g. to heavy metal, nickel, and chromium), and with workers in the leather, textile, and wood industries [3, [7] [8] [9] [10] . Sinonasal tract malignancies most commonly affect the maxillary sinus (about 60%), followed by the nasal cavity (about 22%), ethmoid sinus (about 15%), and frontal and sphenoid sinuses (3%) [3, [8] [9] [10] . In this case, no association with the risk factors was found. A strong etiological relationship between transitional cell carcinoma and the human papilloma virus (HPV) has been suggested by some recent studies [11, 12] . Cervical lymph node metastasis develops in up to 20% of the patients, with rare distant metastasis [3, 10] .
In our case there was no cervical lymphadenopathy. Treatment depends on TNM staging [3] . T1 and T2 nasal tumors are treated by surgical resection, while T3 and T4 tumors receive postoperative radiotherapy. Various surgical approaches like lateral rhinotomy or medial maxillectomy or an end bloc ethmoidectomy are done for superior and lateral nasal cavity carcinomas [13] . . This difference was statistically significant and was greater than in other histological groups. Another observation was that NKCa in men carried a better prognosis than in women where the five-year survival rates were 40% and 13% respectively. A recent study has also shown that NKCas of the sinonasal tract have a higher prevalence of high risk HPV DNA than other types of carcinomas in this region [11] . In conclusion, sinonasal transitional cell carcinoma is a rare malignancy of the nose and paranasal sinuses and should be recognized as a distinct clinicopathologic entity to determine the best treatment modality and to better predict the outcome of treatment. Synonyms of this tumor should be standardized to avoid confusion and misdocumentation.
